General

Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018

Akelos -1018 for Chronic Neuropathic Pain NEW YORK, NY, UNITED STATES, April 16, 2025 /⁨EINPresswire.com⁩/ -- Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018 Patent Covers Inventions Licensed from Weill Cornell Medicine AKE- …

Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018
Akelos -1018 for Chronic Neuropathic Pain

NEW YORK, NY, UNITED STATES, April 16, 2025 /⁨EINPresswire.com⁩/ -- Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018

Patent Covers Inventions Licensed from Weill Cornell Medicine

AKE- …
Read More

Tags:

Previous Article

Fifteen Thomson Federal Prison Staff Member Exposed and Hospitalized

Next Article

Satpreet Singh Presents Landmark Research on Superintelligent AI Risks in Supply...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Factory or Extended: Premier Auto Protect Reveals 2025’s Best Warranty for New Cars

Factory or Extended: Premier Auto Protect Reveals 2025’...

From $27.2 Billion to $42.4 Billion : The Growth of the Global Railway System Market Forecast, 2021-2031

From $27.2 Billion to $42.4 Billion : The Growth of the...

Firebird Shower Glass Design Expands Custom Glass Solutions Across the Dallas-Fort Worth Area

Firebird Shower Glass Design Expands Custom Glass Solut...